dihydrolipoamide dehydrogenase deficiency |
Disease ID | 1031 |
---|---|
Disease | dihydrolipoamide dehydrogenase deficiency |
Synonym | chronic familial methaemoglobin reductase deficiency chronic familial methemoglobin reductase deficiency congenital dpnh-methemoglobin-reductase deficiency congenital infantile lactic acidosis due to lad deficiency congenital nadh-methemoglobin-reductase deficiency cytochrome b5 reductase deficiency cytochrome b5 reductase deficiency cytochrome b>5< reductase deficiency cytochrome-b reductase deficiency cytochrome-b reductase deficiency (disorder) deficiency of cytochrome-b5 reductase deficiency of cytochrome-b5 reductase (disorder) deficiency of cytochrome-b5 reductase deficiency of cytochrome-b5 reductase (disorder) deficiency of cytochrome-b>5< reductase deficiency of cytochrome-b>5< reductase (disorder) deficiency of diaphorase deficiency of dihydrolipoamide dehydrogenase deficiency of dihydrolipoamide dehydrogenase (disorder) deficiency of lipoamide reductase (nadh) diaphorase deficiency dihydrolipoamide dehydrogenase deficiency (disorder) dihydrolipoyl dehydrogenase deficiency dld - dihydrolipoamide dehydrogenase deficiency dld deficiency dldd dpnh methaemoglobin reductase deficiency dpnh methemoglobin reductase deficiency dpnh-methaemoglobin reductase deficiency dpnh-methemoglobin reductase deficiency e3 e3 deficiency lactic acidosis due to lad deficiency lipoamide dehydrogenase deficiency lipoamide dehydrogenase deficiency, lactic acidosis due to maple syrup urine disease with lactic acidosis maple syrup urine disease, type iii methemoglobinemia due to deficiency of methemoglobin reductase methemoglobinemia, congenital, autosomal recessive nadh cytochrome b5 reductase deficiency nadh diaphorase deficiency nadh methemoglobin reductase deficiency nadh-cytochrome b5 reductase deficiency nadh-dependent methemoglobin reductase deficiency nadh-methaemoglobin reductase deficiency nadh-methemoglobin reductase deficiency |
Orphanet | |
OMIM | |
DOID | |
UMLS | C0268193 |
SNOMED-CT | |
Comorbidity | UMLS | Disease | Sentences' Count(Total Sentences:1) |
Curated Gene | Entrez_id | Symbol | Resource(Total Genes:2) |
Inferring Gene | (Waiting for update.) |
Text Mined Gene | (Waiting for update.) |
Locus | (Waiting for update.) |
Disease ID | 1031 |
---|---|
Disease | dihydrolipoamide dehydrogenase deficiency |
Integrated Phenotype | HPO | Name(Total Integrated Phenotypes:12) HP:0000961 | Cyanosis HP:0002179 | Opisthotonus HP:0000486 | Squint eyes HP:0000252 | Small head circumference HP:0001263 | Developmental retardation HP:0002875 | Exertional dyspnea HP:0012119 | Methemoglobinemia HP:0002315 | Headaches HP:0001510 | Growth deficiency HP:0001901 | Abnormally shaped erythrocytes HP:0001276 | Hypertonia HP:0001249 | Mental retardation |
Text Mined Phenotype | HPO | Name | Sentences' Count(Total Phenotypes:1) |
Disease ID | 1031 |
---|---|
Disease | dihydrolipoamide dehydrogenase deficiency |
Manually Symptom | (Waiting for update.) |
Text Mined Symptom | UMLS | Name | Sentences' Count(Total Symptoms:1) |
Manually Genotype(Total Manually Genotypes:3) | |||
---|---|---|---|
Gene | Mutation | DOI | Article Title |
DLD | c.685G>T in both | doi:10.1038/gim.2016.8 | Expanded carrier screening in an infertile population: how often is clinical decision making affected? |
DLD | p.G229C17 | doi:10.1038/gim.2015.123 | Expanded genetic screening panel for the Ashkenazi Jewish population |
DLD | p.Y35X | doi:10.1038/gim.2015.123 | Expanded genetic screening panel for the Ashkenazi Jewish population |
Text Mining Genotype(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
All Snps(Total Genotypes:3) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
snpId | pubmedId | geneId | geneSymbol | diseaseId | sourceId | sentence | score | Year | geneSymbol_dbSNP | CHROMOSOME | POS | REF | ALT |
rs121964990 | 23478190 | 1738 | DLD | umls:C0268193 | BeFree | The diagnosis of DLD deficiency was possible only after genome-wide linkage analysis, confirmed by a homozygous mutation (p.G229C) in the DLD gene, previously reported in patients with the same geographic origin. | 0.242442977 | 2013 | DLD | 7 | 107915506 | G | T |
rs121965009 | 1400360 | 1727 | CYB5R3 | umls:C0268193 | UNIPROT | Enzymatic instability of NADH-cytochrome b5 reductase as a cause of hereditary methemoglobinemia type I (red cell type). | 0.36 | 1992 | CYB5R3 | 22 | 42630899 | C | T |
rs201232518 | 9886302 | 1727 | CYB5R3 | umls:C0268193 | UNIPROT | Molecular basis of hereditary methaemoglobinaemia, types I and II: two novel mutations in the NADH-cytochrome b5 reductase gene. | 0.36 | 1998 | CYB5R3 | 22 | 42627616 | G | A |
GWASdb Annotation(Total Genotypes:1) | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chr | Pos | SNP_Id | RefGene | EnsemblGene | ENCODE_Factor | ENCODE_TFBS | Chromosome_interaction | GTEx_eQTL | SNP_TFBS_affinity_GWAS3D | SNP_miRNA_target_affinity_PolymiRTS | SNP_splicing_effect_Skippy | SNP_splicing_effect_MutPred_Splice | SNP_ns_protein_effect_dbNSFP | SNP_syn_effect_Silva | SNP_phosphorylation_effect_PhosSNP | PhastCons_score | PhyloP_score | GERP++_RS | Segway_state | Ancestral_allele | ESP_AF | ESP_AFR | ESP_AFR | ESP_EUR | TG_ASN | TG_AMR | TG_AFR | TG_EUR | Type | Consequence | bStatistic | EncH3K27Ac | EncH3K4Me1 | EncH3K4Me3 | EncNucleo | OMIM | Clinvar |
22 | 43019632 | rs137127 | NM_001171660,CYB5R3 | NM_001129819,CYB5R3 | NM_001171661,CYB5R3 | NM_007326,CYB5R3 | NM_000398,CYB5R3 | ENST00000396303,ENSG00000100243 | ENST00000361740,ENSG00000100243 | ENST00000396309,ENSG00000100243 | ENST00000352397,ENSG00000100243 | ENST00000407623,ENSG00000100243 | ENST00000414587,ENSG00000100243 | ENST00000407332,ENSG00000100243 | ENST00000470741,ENSG00000100243 | ENST00000402438,ENSG00000100243 | TFP.EBF1 | TFP.TCF12 | MCV-17 | NA | chr22,43010001,43020000,chr22,42970001,42980000,28,Hi-C | chr22,43010001,43020000,chr16,70010001,70020000,64,Hi-C | chr22,43010001,43020000,chrX,111850001,111860000,5,Hi-C | chr22,43010001,43020000,chr22,42400001,42410000,7,Hi-C | chr22,43010001,43020000,chr3,192740001,192750000,8,Hi-C | chr22,43010001,43020000,chr9,31220001,31230000,12,Hi-C | chr22,43010001,43020000,chr22,43470001,43480000,6,Hi-C | chr22,43010001,43020000,chr22,45040001,45050000,8,Hi-C | NA | LM4,3.3653 | LM12,2.0562 | LM35,2.662 | LM40,3.0482 | LM57,1.3119 | NA | NA | NA |
GWASdb Snp Trait(Total Genotypes:0) | |
---|---|
(Waiting for update.) |
Mapped by lexical matching(Total Items:1) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0001263 | Global developmental delay | MP:0002084 | abnormal developmental patterning | abnormal systematic arrangement of the developing body along an axis |
Mapped by homologous gene(Total Items:12) | ||||
---|---|---|---|---|
HP ID | HP Name | MP ID | MP Name | Annotation |
HP:0002179 | Opisthotonus | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0001263 | Global developmental delay | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0012119 | Methemoglobinemia | MP:0010957 | abnormal aerobic respiration | any anomaly in the process of enzymatic release of energy from organic compounds (especially carbohydrates and fats) which requires oxygen as the terminal electron acceptor |
HP:0001901 | Polycythemia | MP:0013241 | embryo tissue necrosis | morphological changes resulting from pathological death of some or all embryo tissue; usually due to irreversible damage |
HP:0001510 | Growth delay | MP:0020169 | increased thyroid gland weight | higher than average weight of the thyroid gland |
HP:0002315 | Headache | MP:0020137 | decreased bone mineralization | decrease in the rate at which minerals are deposited into bone |
HP:0001276 | Hypertonia | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0001249 | Intellectual disability | MP:0020316 | decreased vascular endothelial cell proliferation | decrease in the expansion rate of any vascular endothelial cell population by cell division |
HP:0000486 | Strabismus | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0000252 | Microcephaly | MP:3000003 | abnormal Ebner's gland morphology | any structural anomaly of the serous salivary glands which reside adjacent to the moats surrounding the circumvallate and foliate papillae just anterior to the posterior third of the tongue, anterior to the terminal sulcus; these exocrine glands secrete l |
HP:0000961 | Cyanosis | MP:0013781 | abnormal mammary gland luminal epithelium morphology | any structural anomaly of the inner cell layer of the mammary epithelium bilayer that lines the luminal surface of mammary gland ducts and alveoli; luminal cells have only limited contact with the underlying basement membrane and surrounding connective ti |
HP:0002875 | Exertional dyspnea | MP:0013405 | increased circulating lactate level | greater amount of lactate in the blood which is produced from pyruvate by lactate dehydrogenase |
Disease ID | 1031 |
---|---|
Disease | dihydrolipoamide dehydrogenase deficiency |
Case | (Waiting for update.) |